The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Shackelford Jason T since 2014.
The trader's CIK number is 1595312.
At the time of the last reporting, Shackelford Jason T was the Prin Fin. & Acct. Officer of Oncternal Therapeutics, Inc.. (stock ticker symbol ONCT).
Also see all insider trading activities at Oncternal Therapeutics, Inc..
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2018 | GTXI | 0 | $0 | 12,369 | $212,113 | 0 | $0 |
2014 | GTXI | 10,000 | $9,170 | 0 | $0 | 0 | $0 |
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2018-06-20 | GTXI | Sale | 9,279 | 19.00 | 176,347 |
2018-01-05 | GTXI | Sale | 3,090 | 11.57 | 35,766 |
2014-08-07 | GTXI | Buy | 10,000 | .92 | 9,170 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Shackelford Jason T (Prin Fin. & Acct. Officer of Oncternal Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.